HealthQuill Teva Pharmaceuticals
The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable treatments for its 84 million patients in the bloc.
Drugs Health Pharma

Teva unveils insights on switching schizophrenia patients to Uzedy

September 24, 2024: Teva Pharmaceuticals presented new research demonstrating effective strategies for switching adult patients with schizophrenia from Perseris to Uzedy (risperidone extended-release.

Read More
Israelā€™s Teva Pharmaceuticals will start selling a generic version of Novo Nordiskā€™s type 2 diabetic drug Victoza in the US market.
Drugs Health Pharma

Teva to sell generic version of Novo Nordiskā€™s diabeticĀ drug in US

Israelā€™s Teva Pharmaceuticals will start selling a generic version of Novo Nordiskā€™s type 2 diabetic drug Victoza in the US market.

Read More
Israelā€™s Teva PharmaceuticalsĀ has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to treat a rare hormonal disorder.
Drugs Medical Pharma

Israel’s Teva Pharmaceuticals sue Corcept, Optime over drug monoploy

Israelā€™s Teva PharmaceuticalsĀ has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to.

Read More